Eliane Morel

1.1k total citations
19 papers, 921 citations indexed

About

Eliane Morel is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Eliane Morel has authored 19 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cellular and Molecular Neuroscience, 5 papers in Molecular Biology and 5 papers in Cognitive Neuroscience. Recurrent topics in Eliane Morel's work include Neuroscience and Neuropharmacology Research (7 papers), Epilepsy research and treatment (3 papers) and Pharmacological Receptor Mechanisms and Effects (3 papers). Eliane Morel is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Epilepsy research and treatment (3 papers) and Pharmacological Receptor Mechanisms and Effects (3 papers). Eliane Morel collaborates with scholars based in France, United States and Norway. Eliane Morel's co-authors include D. J. Sanger, Ghislaine Perrault, B. Živković, Branimir Ẑivković, B. Scatton, D. Joly, Ronan Depoortère, Jesús Bénavidès, Caroline Cohen and Kenneth G. Lloyd and has published in prestigious journals such as Neuroscience & Biobehavioral Reviews, Journal of Pharmacology and Experimental Therapeutics and Psychopharmacology.

In The Last Decade

Eliane Morel

18 papers receiving 838 citations

Peers

Countries citing papers authored by Eliane Morel

Since Specialization

Citations

This map shows the geographic impact of Eliane Morel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eliane Morel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eliane Morel more than expected).

Fields of papers citing papers by Eliane Morel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eliane Morel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eliane Morel. The network helps show where Eliane Morel may publish in the future.

Co-authorship network of co-authors of Eliane Morel

This figure shows the co-authorship network connecting the top 25 collaborators of Eliane Morel. A scholar is included among the top collaborators of Eliane Morel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eliane Morel. Eliane Morel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Psychopharmacological Profile of Amisulpride: An Antipsychotic Drug with Presynaptic D2/D3 Dopamine Receptor Antagonist Activity and Limbic Selectivity 1997 ·Journal of Pharmacology and Experimental Therapeutics ·Ghislaine Perrault, Ronan Depoortère, Eliane Morel, D. J. Sanger, B. Scatton	190
2	Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem 1996 ·European Journal of Pharmacology ·D. J. Sanger, Eliane Morel, Ghislaine Perrault	91
3	Le traitement de la liaison chez l'enfant: études expérimentales 1994 ·Eliane Morel	2
4	Recent developments in the behavioral pharmacology of benzodiazepine (ω) receptors: Evidence for the functional significance of receptor subtypes 1994 ·Neuroscience & Biobehavioral Reviews ·D. J. Sanger, Jesús Bénavidès, Ghislaine Perrault, Eliane Morel, Caroline Cohen, D. Joly, Branimir Ẑivković	126
5	traitement de la liaison chez l'enfant : études expérimentales 1994 ·Travaux neuchâtelois de linguistique ·Eliane Morel	5
6	Repeated treatment with alpidem, a new anxiolytic, does not induce tolerance or physical dependence 1993 ·Neuropharmacology ·Ghislaine Perrault, Eliane Morel, D. J. Sanger, Branimir Ẑivković	15
7	Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem. 1992 ·Journal of Pharmacology and Experimental Therapeutics ·Ghislaine Perrault, Eliane Morel, D. J. Sanger, B. Živković	87
8	LACK OF TOLERANCE AND PHYSICAL DEPENDENCE AFTER TREATMENT WITH ALPIDEM, A NEW IMIDAZOPYRIDINE ANXIOLYTIC, IN MICE 1992 ·Behavioural Pharmacology ·Ghislaine Perrault, Eliane Morel, D. J. Sanger, B. Živković	1
9	Animal models of anxiety and the development of novel anxiolytic drugs 1991 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·D. J. Sanger, Ghislaine Perrault, Eliane Morel, (unknown), Branimir Ẑivković	18
10	Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics 1990 ·European Journal of Pharmacology ·Ghislaine Perrault, Eliane Morel, D. J. Sanger, Branimir Ẑivković	84
11	Pharmacological and Behavioral Profile of Alpidem as an Anxiolytic 1990 ·Pharmacopsychiatry ·B. Živković, Eliane Morel, D. Joly, Gh. Perrault, D. J. Sanger, Kenneth G. Lloyd	72
12	Differential neuropsychopharmacological profiles of NMDA antagonists: Ifenprodil-like, PCP-like and CPP-like compounds 1990 ·European Journal of Pharmacology ·Gh. Perrault, Eliane Morel, (unknown), D. J. Sanger, B. Živković	7
13	The interaction between zolpidem and β-CMC: a clue to the identification of receptor sites involved in the sedative effect of zolpidem 1988 ·European Journal of Pharmacology ·Ghislaine Perrault, Eliane Morel, D. J. Sanger, Branimir Ẑivković	13
14	In vivo interaction of zolpidem with central benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the omega 1 (BZD1) subtype. 1988 ·Journal of Pharmacology and Experimental Therapeutics ·Jesús Bénavidès, (unknown), A Dubois, Ghislaine Perrault, Eliane Morel, B. Živković, B. Scatton	80
15	The behavioral profile of zolpidem, a novel hypnotic drug of imidazopyridine structure 1987 ·Physiology & Behavior ·D. J. Sanger, Ghislaine Perrault, Eliane Morel, D. Joly, B. Živković	57
16	Grossularine-1 and grossularine-2, alpha carbolines from Dendrodoa grossularia, as possible intercalative agents. 1987 ·PubMed ·Nicole Helbecque, (unknown), Jacques Bernier, Eliane Morel, Michèle Guyot, Jean‐Pierre Hénichart	38
17	Anti-apomorphine effects of phenothiazine drug metabolites 1987 ·Psychopharmacology ·Eliane Morel, Kenneth G. Lloyd, Svein G. Dahl	12
18	[alpha-Acyl indole type alkaloids: study of their antiviral and local anesthetic properties (author's transl)]. 1978 ·PubMed ·(unknown), (unknown), (unknown), Michel Lebœuf, (unknown), (unknown), Eliane Morel, (unknown)	3
19	[Role of central catecholamines in the psychostimulant activity of pyrovalerone]. 1976 ·PubMed ·(unknown), Eliane Morel, (unknown), (unknown)	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact